Results 31 to 40 of about 373,570 (310)
Рациональная фармакотерапия в кардиологии, 2015 Aim: to study cerebral blood flow and cholesterol metabolism in menopausal women with arterial hypertension (AH); to evaluate dynamics of cerebral blood flow parameters and plasma lipid concentrations in these patients during 6-month antihypertensive and
V. V. Yakusevich +3 more
doaj +1 more source
Hypertension and arterial stiffness [PDF]
The Journal of Clinical Hypertension, 2019 [no abstract available]
Simona Lattanzi +2 more
openaire +3 more sources
Immunity, Inflammation and Disease, 2021 Introduction Although most patients recover within several weeks after acute COVID‐19, some of them develop long‐lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID‐19.
Nikolina Basic‐Jukic +7 more
doaj +1 more source
Frontiers in Medicine, 2023 Cystinuria is a rare genetic disorder inherited by an autosomal recessive pattern which affects the transmembrane transporter for the base amino acid cystine. It has a general prevalence of 1 in 7000 with demographic variations.
Ema Ivandic +9 more
doaj +1 more source
Symposium 2: New renal protection strategies in mellitus diabetes type 2
Revista de la Sociedad Argentina de Diabetes, 2022 In recent years, the NKF National Kidney Foundation modified the term "diabetic nephropathy" which is only used for biopsy-confirmed pathology using the termof diabetic kidney disease (CKD) in order to understand that some patients with diabetes can have
Alicia Elbert
doaj +1 more source
Pulmonary arterial hypertension [PDF]
Medicina, 2007 Pulmonary arterial hypertension is a life-threatening, progressive disorder of pulmonary blood vessels leading to an increase in pressure in pulmonary artery. Diagnosis is based on a mean pulmonary artery pressure of more than 25 mmHg at rest or more than 30 mmHg during exercise. No cure exists for it yet.
openaire +2 more sources
Arterial stiffness and hypertension [PDF]
Clinical Hypertension, 2018 Measures of the functional and structural properties of blood vessels can be used to assess preclinical stage of vascular disorders. Recent experimental and population studies show that arterial stiffening precedes development of high blood pressure, and can be used to predict future cardiovascular events.
openaire +4 more sources
Pulmonary Arterial Hypertension
Journal of the American College of Cardiology, 2008 Significant advances in the treatment of pulmonary arterial hypertension (PAH) have occurred over the last 10 years, starting with the approval of epoprostenol in 1998. Subsequently, multiple additional medications have received approval, including a subcutaneous prostacyclin, an inhaled prostacyclin, and oral medications in 2 separate classes.
Kelly Chin, Lewis J. Rubin
openaire +3 more sources
Pulmonary arterial hypertension [PDF]
Internal and Emergency Medicine, 2009 In Internal and Emergency Medicine, Wu and coworkers [1] review the topic of pulmonary arterial hypertension. Overall, their article is sound and pertinent; however, some issues deserve comments. First, the value of chest radiography in the diagnostic process is somewhat overlooked.
Aydin Uzunpinar, Mehmet Cilingiroglu
openaire +6 more sources
Pulmonary Circulation, 2023 Approximately 25%–30% of patients diagnosed with idiopathic pulmonary arterial hypertension (PAH) have a clustered underlying Mendelian genetic cause and should be classified as heritable PAH (HPAH).
Kae‐Woei Liang +4 more
doaj +1 more source